Last update 08 May 2025

CD39/69 double-negative TIL(Iovance Biotherapeutics)

Overview

Basic Info

Drug Type
TIL therapy
Synonyms-
Target-
Action-
Mechanism
Lymphocyte replacements
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseRespiratory Diseases+ [2]
Active Indication
Breast CancerHead and Neck NeoplasmsMelanoma+ [2]
Inactive Indication-
Originator Organization
Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.
Active Organization
Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with CD39/69 double-negative TIL(Iovance Biotherapeutics)
Login to view more data
100 Translational Medicine associated with CD39/69 double-negative TIL(Iovance Biotherapeutics)
Login to view more data
100 Patents (Medical) associated with CD39/69 double-negative TIL(Iovance Biotherapeutics)
Login to view more data
100 Deals associated with CD39/69 double-negative TIL(Iovance Biotherapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPreclinical
United States
Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.
01 Jan 2021
Head and Neck NeoplasmsPreclinical
United States
Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.
01 Jan 2021
MelanomaPreclinical
United States
Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.
01 Jan 2021
Non-Small Cell Lung CancerPreclinical
United States
Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.
01 Jan 2021
Ovarian CancerPreclinical
United States
Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.
01 Jan 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free